HICAP User Guide

Guide for users of the HICAP video capsule endoscopy service

Step 1

Hicap Combo

Add patient and prepare equipment

  • In HICAPROC set up your patient and create a new order (for a guide on that, please check the OpenBrolly user guide)
  • If you expect and expedited report, let us know with an email to diagnostic@corphealth.co
  • Ensure IT compatibility of the computer you will use to upload the video (see IT readiness guide next to the FAQ)

Step 2

Capsule And Patient

Run capsule endoscopy procedure

  • Make sure that the patient is well prepared
  • Run procedure
  • Receive recorder back from patient

Step 3

RAPID Anonymize

Download the video from the recorder

  • Download and compile video with RAPID
  • Open video in RAPID
  • “Save De-Identified Video As” and note the folder name in HICAPROC (tip: you find the de-indentifying function under ‘File > Save > Save Video’)

Step 4

Upload Combo

Upload the video

  • Open a browser (recent version of Google Chrome, Microsoft Edge, or Mozilla Firefox)
  • Connect to our customer portal at “https://videoupload.corphealth.co
  • Enter the de-identified folder name
  • Enter all required data for the reading request
  • Select the folder where the video was stored for upload to the CorporateHealth portal

Step 5

Hicao Order

Receive report

  • When the report is ready, an alert will be sent to the user ordering the investigation and the department’s inbox
  • Pick-up the report in HICAPROC
  • If you have any questions regarding the results, please send an email to “diagnostic@corphealth.co” or directly call your medical contact which you can find in your “home” tab on our client portal

Medtronic PillCam SB Indications, Contraindications and Risks

Medtronic describes the indications for use, contra indications, and procedure risks for their PillCam SB:

Indications for Use

  • The PillCam Platform with PillCam SB capsules is intended for visualization of the small bowel mucosa and:
    • May be used in the visualization of lesions that may be a source of obscure bleeding (either overt or occult) not detected by upper and lower endoscopy
    • May be used in the visualization of lesions that may be potential causes of iron deficiency anemia (IDA) not detected by upper and lower endoscopy
    • May be used in the visualization and monitoring of lesions that may indicate Crohn’s disease not detected by upper and lower endoscopy
  • The PillCam Platform with PillCam SB capsules may be used as a tool in the detection of abnormalities of the small bowel and is intended for use in adults and children from two years of age
  • The Suspected Blood Indicator (SBI) feature is intended to mark frames of the video suspected of containing blood or red areas

Contraindications

  • Patients with known or suspected GI obstructions, strictures or fistulas based on the clinical picture or pre-procedure testing and profile
  • Patients with cardiac pacemakers or other implanted electromedical devices
  • Patients with swallowing disorders

Procedure Risk Information

  • The risks of PillCam capsule endoscopy include capsule retention, aspiration and skin irritation
  • Endoscopic placement may present additional risks
  • Medical, endoscopic or surgical intervention may be necessary to address any of these complications, should they occur
  • After ingesting the PillCam SB capsule and until it is excreted, patients should not be near any source of powerful electromagnetic fields, such as one created near an MRI device
  • Please refer to the product user manual for detailed information
 Medtronic / Given Imaging “PillCam Capsule Endoscopy. User Manual RAPID v8.0”, March 2013

Same prep CHI-CCE and Colonoscopy

Khoury et al. find that is it feasible to create a tandem offering, where a colonoscopy could be conducted right after a capsule endoscopy. That way for over 80% of patients that would have required a follow-up, invasive procedure, a second prep might have been avoided.

Khoury, Marwan et al. “Enabling Tandem Procedure of Colonoscopy Following Colon Capsule Endoscopy in Colorectal Cancer Screening.” Accessed November 22, 2016. https://www.ueg.eu/education/document/enabling-tandem-procedure-of-colonoscopy-following-colon-capsule-endoscopy-in-colorectal-cancer-screening/115476
Link.

Clinical Practice

CCE is approved across all of Europe, Japan, Canada, and other countries as a viable procedure for colorectal cancer screening. Until recently, its application was limited by a lack of clinical proof and the ability to cost effectively deliver a high-quality service to large populations.

The CAREforCOLON clinical trial program conducted the trials mentioned above to provide a baseline that shows how well CCE compares to traditional colonoscopy as well as CT colonography. Delivering the trial procedures as-a-service validated its applicability in clinical practice. A fourth, pivotal trial with over 2,000 patients of the national Danish bowel cancer screening program has finished pre-trial phase and starts patient recruitment in the summer of 2020.

To conduct a robust evaluation of service delivery, in Scotland the Scottish Capsule Program – SCOTCAP, was launched in June 2019 and concluded after nearly 500 patients in April 2020. Here, symptomatic and surveillance patients were provided with a managed CCE service that CHI delivered in collaboration with Medtronic and the NHS Scotland. Its goal was to assess the ability to roll that service out across all of Scotland. That plan is currently being put in place.